Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment of central nervous system and neuroendocrine system disorders.
Your partner for contract development and production of biopharmaceuticals. The company is primarily engaged in development, clinical testing, production and analysis of proteins for human therapeutic or diagnostic use according to international standards.
A biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancer. It has research, development and manufacturing facilities in the U.S., and marketing organizations in Europe and Australia.
Their mission is to optimize the therapy and prevention of disease in populations in the US and abroad through regulatory support, innovative epidemiological research, education, and product development.
GMP Contract Development & Manufacturing Organization (CDMO) delivering research, process development, and GMP manufacturing services. With more than 25 years of experience, the expression and purification of proteins and viruses is Paragon’s core competency, having produced thousands of proteins and viruses for leading global pharmaceutical and biotechnology companies, as well as government agencies.
Compounding and research pharmacy with a focus in drug delivery systems, primarily in the topical therapeutic application of drugs. PDL has developed several new compounds for the management of pain and nausea, especially for the terminally ill hospice patient.
Antibiotic discovery, using proprietary technology as a platform, for growing previously unculturable microorganisms in the laboratory. Includes publications, related news, and careers in Cambridge, Massachusetts.
Discovers, develops, manufactures and sells pharmaceutical and nutritional products such as drug delivery systems, antibiotics and prepared infant formulas. Includes investor an investor relations area, and a career center. (NYSE: ABT).
Supplies components for genomic studies, and provides research, development and production services for clinical manufacturing. Includes details of products and technical resources. Headquarters in Liege, Belgium.
Discovers, develops, manufactures and markets isoflavonoids for menopausal non-prescription drugs, and multiple signal transduction regulator drugs for cancer. Includes technological overview, and history of company, with offices in Europe and North America, and headquarters in North Ryde, New South Wales. (Nasdaq: NVGN)
Developing therapies for neurological disorders such as spinal cord injuries, neurodegenerative diseases and glaucoma. Features explanation of technology and details of clinical studies. Los Angeles, California, USA.
Virinova has developed a novel virus diagnostic technology for process control and diagnostic monitoring of viral infections. No antibodies or PCR is required and the method is suitable for all virus types including unknown viruses. It allows the direct detection of virus particles in minutes.
Site contains overview of new anti-infective technology developed by the company and problems of drug resistance in general. Bacterial Transforming Agents change antibiotic-resistant bacteria, e.g. MRSA, into antibiotic-susceptible bacteria.
Research into Optimised Human Health through Natural Nutriture, with minimal use of dietary supplements and natural medicines, if at all. Eradication of AIDS, Parasites, Cancer, Cardiovascular Disease, and premature aging.
Canadian company providing products and services in the research and development of pharmaceuticals, including the sale of research quantities of specialty chemicals and brokering of scale-up and custom synthesis contracts.
Develops and commercializes potentially improved versions of widely-prescribed drugs, designed to offer meaningful improvements in patient outcome through reduced side effects, increased efficacy, or improved dosage forms. (Nasdaq: SEPR).
Early stage drug discovery opportunities, research expertise and facilities, and intellectual property available for licensing from the Strathclyde Institute for Drug Research, University of Strathclyde, Glasgow, Scotland.
Research-based biopharmaceutical company seeking to discover and develop new healthcare solutions to treat and diagnose crucial unmet medical conditions in the neurological and oncological sectors. Padua, Italy.